• 1. A new enantioselective synthesis of antiobesity drug lorcaserin
  Ganesh S. Ghotekar,Devidas A. More,Viswanadh Nalla,M. Muthukrishnan New J. Chem. 2019 43 16876
• 2. A new enantioselective synthesis of antiobesity drug lorcaserin
  Ganesh S. Ghotekar,Devidas A. More,Viswanadh Nalla,M. Muthukrishnan New J. Chem. 2019 43 16876
• 3. Stereocontrolled synthesis of quaternary cyclopropyl esters
  Christopher D. Bray,Fabrizio Minicone Chem. Commun. 2010 46 5867

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes

Introduction to (R)-(+)-3-Chlorostyrene Oxide (CAS No. 62600-71-9)

The compound (R)-(+)-3-Chlorostyrene Oxide, identified by the Chemical Abstracts Service Number (CAS No.) 62600-71-9, is a significant molecule in the field of chiral chemistry and pharmaceutical research. This enantiomerically pure compound has garnered attention due to its unique structural properties and potential applications in the synthesis of biologically active molecules. The stereochemistry of this compound, specifically the (R)-configuration, plays a crucial role in determining its interaction with biological targets, making it a valuable tool in drug discovery and development.

In recent years, the demand for enantiomerically pure compounds has surged in the pharmaceutical industry. This is primarily because the biological activity of a drug molecule is often highly dependent on its stereochemical configuration. Racemic mixtures, which contain equal amounts of both enantiomers, can exhibit vastly different pharmacological profiles, with one enantiomer being therapeutically active while the other may be inactive or even harmful. Therefore, the synthesis and characterization of chiral compounds like (R)-(+)-3-Chlorostyrene Oxide are of paramount importance.

The chemical structure of (R)-(+)-3-Chlorostyrene Oxide consists of a styrene backbone with a chlorine substituent at the 3-position and an epoxide group at the 2-position. This unique arrangement imparts distinct reactivity and functionality to the molecule, making it a versatile intermediate in organic synthesis. The epoxide ring, in particular, is known for its ability to undergo ring-opening reactions with nucleophiles, which can be harnessed to construct complex molecular architectures.

One of the most compelling aspects of (R)-(+)-3-Chlorostyrene Oxide is its potential application in the synthesis of pharmacologically relevant compounds. For instance, epoxides have been widely used as key motifs in the development of antiviral and anticancer agents. The stereochemistry of this compound ensures that any derivatives synthesized from it will retain the (R)-configuration, which is often critical for achieving optimal biological activity. Recent studies have demonstrated that chiral epoxides can serve as effective tools for modulating enzyme activity and receptor binding, thereby opening up new avenues for drug design.

The synthesis of (R)-(+)-3-Chlorostyrene Oxide presents several challenges due to its sensitive stereochemistry. Traditional synthetic routes often require careful control over reaction conditions to ensure high enantioselectivity. Advances in asymmetric synthesis have provided novel methodologies for constructing chiral centers with high precision. For example, biocatalytic approaches using engineered enzymes have emerged as powerful tools for achieving enantioselective transformations. These methods not only improve yield but also reduce environmental impact by minimizing waste and hazardous byproducts.

In addition to its synthetic utility, (R)-(+)-3-Chlorostyrene Oxide has been explored for its potential role in materials science. Epoxides are known for their ability to form cross-linked polymers with high thermal stability and mechanical strength. By incorporating chiral units into these polymers, researchers aim to develop materials with tailored optical and electronic properties. Such materials could find applications in optoelectronics, where precise control over molecular orientation is essential for device performance.

The biological activity of (R)-(+)-3-Chlorostyrene Oxide has also been investigated in detail. Preliminary studies suggest that this compound exhibits moderate affinity for certain biological targets, making it a promising candidate for further pharmacological exploration. However, more comprehensive research is needed to fully elucidate its mechanism of action and therapeutic potential. Collaborative efforts between chemists and biologists are essential to bridge the gap between synthetic chemistry and biological application.

The future prospects of (R)-(+)-3-Chlorostyrene Oxide are vast and multifaceted. As our understanding of chirality and stereoselectivity continues to grow, so does the potential for this compound to contribute to advancements in medicine and materials science. Innovations in synthetic methodologies will further enhance our ability to access complex chiral molecules like this one, paving the way for novel therapeutic agents and functional materials.

• 53631-04-2((3-Chlorophenyl)oxirane)
• 2788-86-5(2-(4-chlorophenyl)oxirane)
• 97466-49-4((2S)-2-(4-chlorophenyl)oxirane)
• 20697-04-5(2-(3-Chlorophenyl)oxirane)
• 646041-19-2(Benzene, 1-chloro-4-[(1R)-1-methoxyethyl]-)
• 646041-14-7(Benzene, 1-chloro-4-[(1S)-1-methoxyethyl]-)
• 78982-97-5(Oxirane, (3,5-dichlorophenyl)-)
• 115648-90-3((S)-(3-Chlorophenyl)oxirane)
• 52909-94-1(2-(3,4-dichlorophenyl)oxirane)
• 21019-51-2((R)-2-(4-Chlorophenyl)oxirane)